<ul class="Section ProvisionList" id="1156114"><li><p class="Subsection amending" id="1156115"><strong><a class="sectionLabel" id="s-175"><span class="sectionLabel">175</span></a></strong> <span class="lawlabel">(1)</span> Section 31.4 of the Act is renumbered as subsection 31.4(1) and is amended by adding the following:</p><section><div class="AmendedText"><ul class="Section ProvisionList" id=""><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Clarification</p><p class="Subsection"><span class="lawlabel">(2)</span> For greater certainty, subsection (1) applies in respect of the following provisions of this Act:</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> section 3, if the contravention of that section involves a therapeutic product;</p></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> subsection 22.1(2), if the contravention of that subsection involves any document or information that relates to a therapeutic product or a sample that is or relates to a therapeutic product;</p></li><li><p class="Paragraph"><span class="lawlabel">(c)</span> subsection 23(6), if the contravention of that subsection involves a conveyance in respect of which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;</p></li><li><p class="Paragraph"><span class="lawlabel">(d)</span> subsection 23(13), if the contravention of that subsection involves a place in which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;</p></li><li><p class="Paragraph"><span class="lawlabel">(e)</span> subsection 24(1), if the contravention of that subsection involves the obstruction or hindering of — or the making of a false or misleading statement to — an inspector who is carrying out duties or functions in relation to a therapeutic product;</p></li><li><p class="Paragraph"><span class="lawlabel">(f)</span> subsection 24(2), if the contravention of that subsection involves anything seized that is or relates to a therapeutic product; and</p></li><li><p class="Paragraph"><span class="lawlabel">(g)</span> subsection 27.3(2), if the contravention of that subsection involves measures that were ordered to be taken in relation to a therapeutic product.</p></li></ul></li></ul></div></section></li><li><div class="hiddenMsg">The following provision is not in force.</div><div class="nif"><p class="Subsection amending" id="1156117"><span class="lawlabel">(2)</span> Subsection 31.4(2) of the Act is amended by adding the following after paragraph (a):</p><section><div class="AmendedText"><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a.1)</span> section 3.1, if the contravention of that section involves a clinical trial that relates to a therapeutic product;</p></li><li><p class="Paragraph"><span class="lawlabel">(a.2)</span> section 3.2, if the contravention of that section involves the terms and conditions of an authorization that authorizes the conduct of a clinical trial that relates to a therapeutic product;</p></li></ul></div></section></div></li></ul>